Development and Validation of the Schedule for the Assessment of Insight in Anxiety Disorders (SAI‐A)
Depression and Anxiety · 2025
DOI: 10.1155/da/8843975 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Depression and Anxiety, 2025. Verfasst von Asala Halaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Mental Health, University of Haifa, Haifa, Israel. Hauptthemen laut MEDLINE: Anxiety Disorders, Awareness, Psychiatric Status Rating Scales. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
There is a growing interest in understanding insight or illness awareness in anxiety; however, most assessment instruments were designed for psychosis. The unique features of anxiety highlight the need for tailored measures to accurately evaluate insight. The aim of this study was to develop and validate the Schedule for the Assessment of Insight in Anxiety (SAI‐A), a clinician‐rated scale for assessing insight in anxiety disorders. We interviewed 46 participants diagnosed with anxiety disorders, conducted SAI‐A interviews, and administered self‐report measures. Using correlation and principal component analysis (PCA), we identified and assessed scale components, ensuring their reliability and consistency. The SAI‐A demonstrated acceptable psychometric properties, including convergent validity with an established self‐report measure ( r = −0.39, p = 0.008) and internal consistency (Cronbach’s α = 0.70). It showed moderate to strong agreement, interrater reliability (weighted kappa = 0.53, intraclass correlation coefficient [ICC] = 0.67), and test–retest reliability (ICC = 0.65). Two distinct insight components emerged: awareness of disorder and need for treatment. Higher overall SAI‐A scores correlated with symptom severity and impairment ( r = 0.56, r = 0.51, p < 0.001, respectively) and medication usage. The SAI‐A is a valid and reliable assessment tool, providing a comprehensive framework for understanding and addressing insight in the context of anxiety disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Community Mental Health, University of Haifa, Haifa, Israel.
- Department of Psychology, The Hebrew University of Jerusalem, Jerusalem, Israel.
- First Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Research Department of Clinical, Education and Health Psychology, University College London, London, UK.
- UCL Institute of Mental Health, Division of Psychiatry, University College London, London, UK.
ORCID-Profile: Asala Halaj, Jonathan D Huppert, George Konstantakopoulos, Anthony S David
Zitieren
APA
Halaj, A., Huppert, J. D., Konstantakopoulos, G., & David, A. S. (2025). Development and Validation of the Schedule for the Assessment of Insight in Anxiety Disorders (SAI‐A). Depression and Anxiety. https://doi.org/10.1155/da/8843975
Vancouver
Halaj A, Huppert JD, Konstantakopoulos G, David AS. Development and Validation of the Schedule for the Assessment of Insight in Anxiety Disorders (SAI‐A). Depression and Anxiety. 2025. doi:10.1155/da/8843975
BibTeX
@article{Halaj2025,
author = {Halaj, Asala and Huppert, Jonathan D and Konstantakopoulos, George and David, Anthony S},
title = {Development and Validation of the Schedule for the Assessment of Insight in Anxiety Disorders (SAI‐A)},
journal = {Depression and Anxiety},
year = {2025},
doi = {10.1155/da/8843975}
}
EUVIMED